U.S. Late-Day Stock Moves: CERE, EPAC, TWOU, MLHR, FOXA

Advances:

• Cerevel Therapeutics (CERE) +124.2%. CERE said its Phase I-B study for its schizophrenia treatment yielded positive results.
• Enerpac Tool (EPAC) +6.8%. EPAC's third-quarter results beat estimates.
• 2U (TWOU) +4.2%. TWOU will acquire edX's assets for $800 million.

Declines:

• Herman Miller (MLHR) -6.8%. MLHR's fourth-quarter backlog disappointed.
• Fox (FOXA) -3.5%. FOXA shares were downgraded from "buy" to "neutral" at Guggenheim.